BrainStorm Cell Therapeutics Inc (BCLI) - Financial and Strategic SWOT Analysis Review



BrainStorm Cell Therapeutics Inc (BrainStorm Cell Therapeutics) formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell products are being developed based on cell therapy platform NurOwn, customized for the treatment of multiple sclerosis, amyotrophic lateral sclerosis, parkinson’s disease, huntington’s disease, autism spectrum disorder, peripheral nerve injury, and other indications. Its proprietary technology NurOwn induces mesenchymal stem cells to secrete high levels of neurotrophic factors to promote the survival of neurons. The company has operations in the US and Israel. BrainStorm Cell Therapeutics is headquartered in New York, the US.

BrainStorm Cell Therapeutics Inc Key Recent Developments

May 07,2020: BrainStorm announces financial results for the first quarter of 2020 and provides a corporate update
Apr 01,2020: David Setboun joins BrainStorm as Executive Vice President and Chief Operating Officer
Mar 31,2020: BrainStorm appoints renowned distinguished economist, Prof. Jacob Frenkel, chairman of the board of directors
Feb 18,2020: BrainStorm announces operational highlights and financial results for the year ended December 31, 2019
Feb 04,2020: BrainStorm CEO to provide company update at the BIO CEO & Investor Conference

This comprehensive SWOT profile of BrainStorm Cell Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BrainStorm Cell Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

BrainStorm Cell Therapeutics Inc - Key Information
BrainStorm Cell Therapeutics Inc - Overview
BrainStorm Cell Therapeutics Inc - Key Employees
BrainStorm Cell Therapeutics Inc - Key Employee Biographies
BrainStorm Cell Therapeutics Inc - Key Operational Heads
BrainStorm Cell Therapeutics Inc - Major Products and Services
BrainStorm Cell Therapeutics Inc - History
BrainStorm Cell Therapeutics Inc - Company Statement
BrainStorm Cell Therapeutics Inc - Locations And Subsidiaries
BrainStorm Cell Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

BrainStorm Cell Therapeutics Inc - Business Description
BrainStorm Cell Therapeutics Inc - Corporate Strategy
BrainStorm Cell Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
BrainStorm Cell Therapeutics Inc - Strengths
BrainStorm Cell Therapeutics Inc - Weaknesses
BrainStorm Cell Therapeutics Inc - Opportunities
BrainStorm Cell Therapeutics Inc - Threats
BrainStorm Cell Therapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

BrainStorm Cell Therapeutics Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



BrainStorm Cell Therapeutics Inc, Key Information
BrainStorm Cell Therapeutics Inc, Key Ratios
BrainStorm Cell Therapeutics Inc, Share Data
BrainStorm Cell Therapeutics Inc, Major Products and Services
BrainStorm Cell Therapeutics Inc, History
BrainStorm Cell Therapeutics Inc, Key Employees
BrainStorm Cell Therapeutics Inc, Key Employee Biographies
BrainStorm Cell Therapeutics Inc, Key Operational Heads
BrainStorm Cell Therapeutics Inc, Other Locations
BrainStorm Cell Therapeutics Inc, Subsidiaries
BrainStorm Cell Therapeutics Inc, Key Competitors
BrainStorm Cell Therapeutics Inc, SWOT Analysis
BrainStorm Cell Therapeutics Inc, Ratios based on current share price
BrainStorm Cell Therapeutics Inc, Annual Ratios
BrainStorm Cell Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



BrainStorm Cell Therapeutics Inc, Performance Chart
BrainStorm Cell Therapeutics Inc, Ratio Charts
 


Lineage Cell Therapeutics Inc (LCTX) - Financial and Strategic SWOT Analysis Review

Lineage Cell Therapeutics Inc (LCTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Global Natural Killer (NK) Cell Therapeutics Market Research Report 2017

Natural Killer (NK) Cell Therapeutics Report by Material, Application, and Geography Global Forecast to 2021 is a professional and in-depth research report on the worlds major regional market conditions,

USD 2850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available